Corrigendum to "A new global assay of coagulation and fibrinolysis" [Thrombosis Research 116/4 (2005) 345-356] (DOI:10.1016/j.thromres.2004.12.009);A new global assay of coagulation and fibrinolysis

Thrombosis Research

Volumn 116, Issue 4, 2005, Pages 345-356

  Goldenberg, Neil A ^a,b   Hathaway, William E ^a,b   Jacobson, Linda ^b   Manco Johnson, Marilyn J ^a,b  

^a CHILDREN S HOSPITAL   (United States)

^b Mountain States Regional Hemophilia and Thrombosis Center   (United States)

Author keywords

Coagulation; Fibrinolysis; Global assay

Indexed keywords

CALCIUM; FIBRINOGEN; PLASMINOGEN; THROMBIN; THROMBOPLASTIN; TISSUE PLASMINOGEN ACTIVATOR;

ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTICLE; AUTOMATION; BLOOD CLOT LYSIS; BLOOD CLOTTING; BLOOD SAMPLING; CALCULATION; CHILD; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HUMAN; MALE; MEASUREMENT; NORMAL HUMAN; PHYSIOLOGY; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SPECTROPHOTOMETRY; THERMOREGULATION;

EID: 22244485660     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2006.06.007     Document Type: Erratum

References (23)

1. S. Butenas, C. van't Veer, and K.G. Mann "Normal" thrombin generation Blood 94 1999 2169 2178
2. H.C. Hemker, and S. Béguin Phenotyping the clotting system Thromb. Haemost. 84 2000 747 750
3. H.C. Hemker, and S. Béguin Thrombin generation in plasma: its assessment via the endogenous thrombin potential Thromb. Haemost. 74 1995 134 138
4. H.C. Hemker, P.L.A. Giesen, M. Ramjee, R. Wagenvoord, and S. Béguin The thrombogram: monitoring thrombin generation in platelet rich plasma Thromb. Haemost. 83 2000 589 591
5. P.L. Turecek, K. Váradi, B. Keil, C. Negrier, E. Berntorp, and J. Astermark Factor VIII inhibitor-bypassing agents act by inducing thrombin generation and can be monitored by a thrombin generation assay Pathophysiol. Haemost. Thromb. 33 2003 16 22
6. T. Quiroga, M. Goycoolea, P.L. Giesen, M. Morales, B. Munoz, and E. Aranda Thrombin generation in platelet-poor plasma is normal in patients with hereditary mucocutaneous hemorrhages Pathophysiol. Haemost. Thromb. 33 2003 30 35
7. M. Giansily-Blaizot, R. Al Dieri, and J.-F. Schved Thrombin generation measurement in factor VII-depleted plasmas compared to inherited factor VII-deficient plasmas Pathophysiol. Haemost. Thromb. 33 2003 36 42
8. C.G. Faber, J. Lodder, F. Kessels, and J. Troost Thrombin generation in platelet-rich plasma as a tool for the detection of hypercoagulability in young stroke patients Pathophysiol. Haemost. Thromb. 33 2003 52 58
9. G. Cvirn, S. Gallistl, B. Leschnik, and W. Muntean Low tissue factor pathway inhibitor (TFPI) together with low antithrombin allows sufficient thrombin generation in neonates J. Thromb. Haemost. 1 2003 263 268
10. G. Cvirn, S. Gallistl, and W. Muntean Effects of antithrombin and protein C on thrombin generation in newborn and adult plasma Thromb. Res. 93 1999 183 190
11. L.O. Mosnier, T. Lisman, H.M. van den Berg, H.K. Nieuwenhuis, J.C. Meijers, and B.N. Bouma The defective down regulation of fibrinolysis in hemophilia A can be restored by increasing the TAFI plasma concentration Thromb. Haemost. 86 2001 1035 1039
12. M. Colucci, B.M. Binetti, M.G. Branca, C. Clerici, A. Morelli, and N. Semeraro Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis Hepatology 38 2003 230 237
13. K. Lottermoser, S. Petras, U. Poge, R. Fimmers, H.J. Hertfelder, and B. Schiermeyer The fibrinolytic system in chronic renal failure Eur. J. Med. Res. 6 2001 372 376
14. T.M. Palabrica, A.C. Liu, M.J. Aronovitz, B. Furie, R.M. Lawn, and B.C. Furie Antifibrinolytic activity of apolipoprotein(a) in vivo: human apolipoprotein(a) transgenic mice are resistant to tissue plasminogen activator-mediated thrombolysis Nat. Med. 1 1995 256 259
15. S. He, K. Bremme, and M. Blombäck A laboratory method for determination of overall haemostatic potential in plasma: I. Method design and preliminary results Thromb. Res. 96 1999 145 156
16. S. He, A. Antovic, and M. Blombäck A simple and rapid laboratory method for determination of haemostasis potential in plasma: II. Modifications for use in routine laboratories and research work Thromb. Res. 103 2001 355 361
17. J.P. Antovic, M. Yngen, C.-G. Östenson, A. Antovic, H.N. Wallen, and G. Jorneskög Thrombin activatable fibrinolysis inhibitor and hemostatic changes with type I diabetes mellitus with and without microvascular complications Blood Coagul. Fibrinolysis 14 2003 551 556
18. S. He, K. Bremme, A. Silveira, M. van Rooijen, and M. Blombäck Hypercoagulation in surgical postmenopausal women having hormone replacement with overdose estradiol Blood Coagul. Fibrinolysis 12 2001 677 681
19. Laboratory measurements of hemostasis and thrombosis S.H. Goodnight W.E. Hathaway Disorders of hemostasis and thrombosis: a clinical guide 2nd ed. 2001 McGraw-Hill New York 20 30
20. A.A. Smith, L.J. Jacobson, B.I. Miller, W.E. Hathaway, and M.J. Manco-Johnson A new euglobulin clot lysis assay for global fibrinolysis Thromb. Res. 112 2003 329 337
21. M.J. Manco-Johnson, R. Nuss, and L. Jacobson Heparin neutralization is essential for accurate measurement of factor VIII activity and inhibitor assays in blood samples drawn from implanted venous access devices J. Lab. Clin. Med. 136 2000 74 79
22. M. Andrew, P. Vegh, M. Johnston, J. Bowker, F. Ofosu, and L. Mitchell Maturation of the hemostatic system during childhood Blood 80 1992 1998 2005
23. D.A. Meh, M.W. Mosesson, J.P. DiOrio, K.R. Siebenlist, I. Hernandez, and D.L. Amrani Disintegration and reorganization of fibrin networks during tissue-type plasminogen activator-induced clot lysis Blood Coagul. Fibrinolysis 12 2001 627 637